UKVIA urges chancellor to level playing field between vaping and nicotine replacement products

Print

The UK Vaping Industry Association (UKVIA) is calling on the government to consider a similar VAT rate for vaping to that currently applied to nicotine replacement therapies (NRT).

e-cig-vaping.jpg

The call comes as chancellor Rishi Sunak is widely reported to be looking at reducing the VAT rate in the wake of the coronavirus as the government last did during the 2008 economic downturn.

In a letter, the UKVIA has urge Sunak to consider a level playing field in regard to the VAT rate between NRT and vaping products, to support adult smokers who would otherwise not quit smoking to make the switch to vaping.

The letter points to the recent Public Health England (PHE) Vaping in England Report which found that when vaping products were used in an attempt to quit, either alone or with licensed medication, success rates were comparable to, if not higher than, licensed medication alone.

It highlights the current VAT gap between NRT products (5%) and vaping (the full 20% VAT and the same as conventional cigarettes) despite the fact that e-cigarettes, while not a cessation product, have significant potential to have a positive impact on public health. This is backed up by research commissioned by the NHS last year which revealed that e-cigs are twice as effective as nicotine patches, gum or sprays for quitting smoking.

John Dunne, director at UKVIA, said: “Whilst the country is still very much in the recovery phase of Covid-19, a significant VAT reduction for vape products would pay back both economically and from a healthcare perspective.”

“A VAT rate for vaping on par with NRT would also support the call in the recent PHE report for smokers to be encouraged to try regulated nicotine vaping products along with smoking cessation medications and behavioural support to increase their chances of successfully stopping smoking.”